Inhibition of Catabolic Pathway of 5-Fluorouracil by 3-Cyano-2,6-dihydroxypyridine in Human Lung Cancer Tissues-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of Catabolic Pathway of 5-Fluorouracil by 3-Cyano-2,6-dihydroxypyridine in Human Lung Cancer Tissues

Published:1994-01 Issue:1 Volume:85 Page:101-105
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Okayasu Takeshi,Sugiyama Kazuhisa,Miyauchi Shun

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.1994.tb02892.x/fullpdf

Reference16 articles.

1. Studies on fluorinated pyrimidines. VIII. Further biochemical and metabolic investigations;Harbers;J. Biol Chem.,1959

2. Studies on fluorinated pyrimidines. XIII. Inhibition of thymidylate synthetase;Hartmann;J. Biol. Chem.,1961

3. Effects of 5-fluorouridine on modified nucleosides in mouse liver transfer RNA;Lu;Biochem. Biophys. Res. Commun.,1976

4. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells;Cory;Cancer Res.,1979

5. Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells;Evans;Cancer Res.,1980

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The oral fluorinated pyrimidines;Investigational New Drugs;2001

2. Preclinica Delle Nuove Molecole Attive Sulle Neoplasie Colorettali;Tumori Journal;2000-05

3. Dihydropyrimidine Dehydrogenase Activity in Human Pancreatic Tumor Tissues;Cancer Investigation;2000-01

4. Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours;British Journal of Cancer;1996-12

5. Leukopenia-Inducing Effect of a Combination of a New 5-Fluorouracil (5-FU)-Derived Drug, BOF-A2 (Emitefur), with Other 5-FU-Derived Drugs or BV-araU (Sorivudine) in Rats;Japanese Journal of Pharmacology;1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3